M1033 — Pharmacotherapy for oud initiated after june 30th of performance period
M1033 is a HCPCS Level II code for pharmacotherapy for oud initiated after june 30th of performance period. It belongs to the Medical Services section. It was terminated on December 31, 2020 and is not valid on new claims.
This code has been terminated
CMS terminated M1033 on December 31, 2020. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for M1033
- Long descriptor
- Pharmacotherapy for oud initiated after june 30th of performance period
- Short descriptor
- Pharmthry for oud afr 6.30
- Added
- January 1, 2019
- Terminated
- December 31, 2020
- BETOS
- Z2
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to M1033
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1033 is not quite right, the correct code is very often within a few positions of it.
- M1025Patients who were in hospice at any time during the performance periodterminated
- M1026Patients who were in hospice at any time during the performance periodterminated
- M1027Imaging of the head (ct or mri) was obtained
- M1028Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
- M1029Imaging of the head (ct or mri) was not obtained, reason not given
- M1030Patients with clinical indications for imaging of the headterminated
- M1031Patients with no clinical indications for imaging of the headterminated
- M1032Adults currently taking pharmacotherapy for oud
- M1034Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
- M1035Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
- M1036Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
- M1037Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
- M1038Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
- M1039Patients with a diagnosis of lumbar spine region infection at the time of the procedure
- M1040Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
- M1041Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
Questions about M1033
What is HCPCS code M1033?
M1033 is a HCPCS Level II code for pharmacotherapy for oud initiated after june 30th of performance period. It sits in the Medical Services section.
Does Medicare cover M1033?
The CMS HCPCS file marks M1033 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is M1033 still valid?
No. M1033 was terminated on December 31, 2020 and should not be used on new claims.